- Home
- APTO vs EDSA Comparison
APTO vs EDSA Comparison
Compare APTO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APTO
- EDSA
- Stock Information
- Founded
- APTO 1986
- EDSA 2015
- Country
- APTO Canada
- EDSA Canada
- Employees
- APTO N/A
- EDSA N/A
- Industry
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- APTO Health Care
- EDSA Health Care
- Exchange
- APTO Nasdaq
- EDSA Nasdaq
- Market Cap
- APTO 6.8M
- EDSA 6.2M
- IPO Year
- APTO N/A
- EDSA N/A
- Fundamental
- Price
- APTO $1.71
- EDSA $2.30
- Analyst Decision
- APTO Strong Buy
- EDSA Strong Buy
- Analyst Count
- APTO 3
- EDSA 1
- Target Price
- APTO $112.00
- EDSA $21.00
- AVG Volume (30 Days)
- APTO 58.8K
- EDSA 23.4K
- Earning Date
- APTO 05-13-2025
- EDSA 05-09-2025
- Dividend Yield
- APTO N/A
- EDSA N/A
- EPS Growth
- APTO N/A
- EDSA N/A
- EPS
- APTO N/A
- EDSA N/A
- Revenue
- APTO N/A
- EDSA N/A
- Revenue This Year
- APTO N/A
- EDSA N/A
- Revenue Next Year
- APTO N/A
- EDSA N/A
- P/E Ratio
- APTO N/A
- EDSA N/A
- Revenue Growth
- APTO N/A
- EDSA N/A
- 52 Week Low
- APTO $1.35
- EDSA $1.55
- 52 Week High
- APTO $50.10
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- APTO 39.84
- EDSA 47.13
- Support Level
- APTO $1.10
- EDSA $2.31
- Resistance Level
- APTO $3.43
- EDSA $2.54
- Average True Range (ATR)
- APTO 0.50
- EDSA 0.11
- MACD
- APTO -0.08
- EDSA -0.03
- Stochastic Oscillator
- APTO 52.09
- EDSA 3.45
Stock Price Comparison Chart: APTO vs EDSA
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.